The Increasing Complexity of Guideline-Directed Medical Therapy for Heart Failure with Reduced Ejection Fraction and Challenges for Real-world Implementation
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
The Increasing Complexity of Guideline-Directed Medical Therapy for Heart Failure with Reduced Ejection Fraction and Challenges for Real-world Implementation ; volume:5 ; number:1 ; day:7 ; month:8 ; year:2023 ; pages:1-8 ; date:12.2023
SN comprehensive clinical medicine ; 5, Heft 1 (7.8.2023), 1-8, 12.2023
- Urheber
-
Soh, Bing Wei Thaddeus
Langille, Jaimie
O’Brien, Kathryn
Glasgow, Jacinta
Murray, Siobhan
Abbas, Syed
O’Connor, Cormac
Arnous, Samer
Kiernan, Thomas
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s42399-023-01530-z
- URN
-
urn:nbn:de:101:1-2023110208091768651527
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:58 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Soh, Bing Wei Thaddeus
- Langille, Jaimie
- O’Brien, Kathryn
- Glasgow, Jacinta
- Murray, Siobhan
- Abbas, Syed
- O’Connor, Cormac
- Arnous, Samer
- Kiernan, Thomas
- SpringerLink (Online service)
Ähnliche Objekte (12)
Guideline-directed medical therapy is similarly effective in heart failure with mildly reduced ejection fraction
Guideline-directed medical therapy is similarly effective in heart failure with mildly reduced ejection fraction
Differences in provider approach to initiating and titrating guideline directed medical therapy in heart failure with reduced ejection fraction
Right ventricular ejection fraction
Vericiguat for Heart Failure with Reduced Ejection Fraction
Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction
Dynamic trajectories of left ventricular ejection fraction in heart failure with improved ejection fraction
Extraction of Ejection Fraction from Echocardiography Notes for Constructing a Cohort of Patients having Heart Failure with reduced Ejection Fraction (HFrEF)
Endostatin a Potential Biomarker for Heart Failure with Preserved Ejection Fraction
Anticoagulants for stroke prevention in heart failure with reduced ejection fraction
Ejection fraction is not sensitive for the identification of high infarct mass
Midwall ejection fraction for assessing systolic performance of the hypertrophic left ventricle
Guideline-directed medical therapy is similarly effective in heart failure with mildly reduced ejection fraction
Guideline-directed medical therapy is similarly effective in heart failure with mildly reduced ejection fraction
Differences in provider approach to initiating and titrating guideline directed medical therapy in heart failure with reduced ejection fraction
Right ventricular ejection fraction
Vericiguat for Heart Failure with Reduced Ejection Fraction
Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction
Dynamic trajectories of left ventricular ejection fraction in heart failure with improved ejection fraction
Extraction of Ejection Fraction from Echocardiography Notes for Constructing a Cohort of Patients having Heart Failure with reduced Ejection Fraction (HFrEF)
Endostatin a Potential Biomarker for Heart Failure with Preserved Ejection Fraction
Anticoagulants for stroke prevention in heart failure with reduced ejection fraction
Ejection fraction is not sensitive for the identification of high infarct mass
Midwall ejection fraction for assessing systolic performance of the hypertrophic left ventricle
Guideline-directed medical therapy is similarly effective in heart failure with mildly reduced ejection fraction
Guideline-directed medical therapy is similarly effective in heart failure with mildly reduced ejection fraction
Differences in provider approach to initiating and titrating guideline directed medical therapy in heart failure with reduced ejection fraction
Right ventricular ejection fraction
Vericiguat for Heart Failure with Reduced Ejection Fraction
Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction
Dynamic trajectories of left ventricular ejection fraction in heart failure with improved ejection fraction
Extraction of Ejection Fraction from Echocardiography Notes for Constructing a Cohort of Patients having Heart Failure with reduced Ejection Fraction (HFrEF)
Endostatin a Potential Biomarker for Heart Failure with Preserved Ejection Fraction
Anticoagulants for stroke prevention in heart failure with reduced ejection fraction
Ejection fraction is not sensitive for the identification of high infarct mass